The problem we are trying to solve is that of drugs that would have never seen the light of day for reasons that have nothing to do with the inherent properties of drug candidates themselves and more to do with… — Vivek Ramaswamy Copy Share Image
Roivant does not view - and has never viewed - Axovant as simply a 'vehicle' for developing intepirdine, but instead as a platform for the development of high-impact drugs in dementia and the neuroscience field more generally. — Vivek Ramaswamy Copy Share Image
The problem we are trying to solve is that of drugs that would have never seen the light of day for reasons that have… — Vivek Ramaswamy Copy Share Image
Roivant does not view - and has never viewed - Axovant as simply a 'vehicle' for developing intepirdine, but instead as a platform for… — Vivek Ramaswamy Copy Share Image
The 'Living-Wage Campaign' at Harvard is like a Boston winter: you know it's going to strike, but wonder only when and how hard. — Vivek Ramaswamy Copy Share Image
I would think the correlation between an era of increased globalization and an increased desire to participate in an entrepreneurial endeavor is not a… — Vivek Ramaswamy Copy Share Image
There is no doubt that the Mindset failure is a major setback for Axovant, but it is not the end of the road. — Vivek Ramaswamy Copy Share Image
I've said all along that we're building Axovant as a lasting company for the long run, not to hand over that upside to a… — Vivek Ramaswamy Copy Share Image
I would not have had the same personal commitment to Alzheimer's disease if it had not been for my mother and my upbringing. — Vivek Ramaswamy Copy Share Image
From a personal standpoint, I consider myself much more of an accidental entrepreneur. I was involved in the entrepreneurship club at Harvard, but I… — Vivek Ramaswamy Copy Share Image
I believe the pharma company of the future isn't going to be old-school. — Vivek Ramaswamy Copy Share Image
In contrast to how tech firms want to disrupt and break things - developing drugs must be incremental and step-by-step. This is the kind… — Vivek Ramaswamy Copy Share Image
I think dementia is the major healthcare threat to our economy and our security. It's a ticking time bomb - we have a whole… — Vivek Ramaswamy Copy Share Image
The thing in Alzheimer's disease to remember, and we remember this all the time at Axovant, is we don't fully understand the way the… — Vivek Ramaswamy Copy Share Image
